Literature DB >> 23744808

Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice.

Anup Ramachandran1, Mitchell R McGill, Yuchao Xie, Hong-Min Ni, Wen-Xing Ding, Hartmut Jaeschke.   

Abstract

UNLABELLED: Acetaminophen (APAP) overdose is a major cause of hepatotoxicity and acute liver failure in the U.S., but the pathophysiology is incompletely understood. Despite evidence for apoptotic signaling, hepatic cell death after APAP is generally considered necrotic in mice and in humans. Recent findings suggest that the receptor interacting protein kinase 3 (RIP3) acts as a switch from apoptosis to necrosis (programmed necrosis). Thus, the aim of the current investigation was to determine if RIP3 is involved in APAP-induced liver cell death. APAP (200-300 mg/kg) caused glutathione depletion and protein adduct formation, oxidant stress, mitochondrial release of apoptosis inducing factor, and nuclear DNA fragmentation resulting in centrilobular necrosis in C57Bl/6J mice. Inhibiting RIP3 protein induction with antisense morpholinos in wild-type animals or using RIP3-deficient mice had no effect on protein adduct formation but attenuated all other parameters, including necrotic cell death, at 6 hours after APAP. In addition, cultured hepatocytes from RIP3-deficient mice showed reduced injury compared to wild-type cells after 24 hours. Interestingly, APAP-induced mitochondrial translocation of dynamin-related protein 1 (Drp1), the initiator of mitochondrial fission, was inhibited by reduced RIP3 protein expression and the Drp1 inhibitor MDIVI reduced APAP-induced cell death at 24 hours. All of these protective effects were lost after 24 hours in vivo or 48 hours in vitro.
CONCLUSION: RIP3 is an early mediator of APAP hepatotoxicity, involving modulation of mitochondrial dysfunction and oxidant stress. Controlling RIP3 expression could be a promising new approach to reduce APAP-induced liver injury, but requires complementary strategies to control mitochondrial dysfunction for long-term protection.
© 2013 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23744808      PMCID: PMC3791212          DOI: 10.1002/hep.26547

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  42 in total

1.  Determination of acetaminophen-protein adducts in mouse liver and serum and human serum after hepatotoxic doses of acetaminophen using high-performance liquid chromatography with electrochemical detection.

Authors:  Kenneth L Muldrew; Laura P James; Leslie Coop; Sandra S McCullough; Howard P Hendrickson; Jack A Hinson; Philip R Mayeux
Journal:  Drug Metab Dispos       Date:  2002-04       Impact factor: 3.922

2.  Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis?

Authors:  Jaspreet S Gujral; Tamara R Knight; Anwar Farhood; Mary Lynn Bajt; Hartmut Jaeschke
Journal:  Toxicol Sci       Date:  2002-06       Impact factor: 4.849

3.  Inhibition of tumour necrosis factor alpha does not prevent experimental paracetamol-induced hepatic necrosis.

Authors:  K J Simpson; N W Lukacs; A H McGregor; D J Harrison; R M Strieter; S L Kunkel
Journal:  J Pathol       Date:  2000-03       Impact factor: 7.996

4.  Acetaminophen hepatotoxicity in tumor necrosis factor/lymphotoxin-alpha gene knockout mice.

Authors:  F Boess; M Bopst; R Althaus; S Polsky; S D Cohen; H P Eugster; U A Boelsterli
Journal:  Hepatology       Date:  1998-04       Impact factor: 17.425

5.  The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis.

Authors:  S Frank; B Gaume; E S Bergmann-Leitner; W W Leitner; E G Robert; F Catez; C L Smith; R J Youle
Journal:  Dev Cell       Date:  2001-10       Impact factor: 12.270

Review 6.  Selective protein covalent binding and target organ toxicity.

Authors:  S D Cohen; N R Pumford; E A Khairallah; K Boekelheide; L R Pohl; H R Amouzadeh; J A Hinson
Journal:  Toxicol Appl Pharmacol       Date:  1997-03       Impact factor: 4.219

7.  Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes.

Authors:  Kazuyoshi Kon; Jae-Sung Kim; Hartmut Jaeschke; John J Lemasters
Journal:  Hepatology       Date:  2004-11       Impact factor: 17.425

8.  Acetaminophen-induced oxidant stress and cell injury in cultured mouse hepatocytes: protection by N-acetyl cysteine.

Authors:  Mary Lynn Bajt; Tamara R Knight; John J Lemasters; Hartmut Jaeschke
Journal:  Toxicol Sci       Date:  2004-04-28       Impact factor: 4.849

9.  Critical role for mixed-lineage kinase 3 in acetaminophen-induced hepatotoxicity.

Authors:  Manju Sharma; Vidya Gadang; Anja Jaeschke
Journal:  Mol Pharmacol       Date:  2012-08-23       Impact factor: 4.436

10.  Acetaminophen-induced inhibition of Fas receptor-mediated liver cell apoptosis: mitochondrial dysfunction versus glutathione depletion.

Authors:  Tamara R Knight; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2002-06-01       Impact factor: 4.219

View more
  113 in total

1.  DNase II activated by the mitochondrial apoptotic pathway regulates RIP1-dependent non-apoptotic hepatocyte death via the TLR9/IFN-β signaling pathway.

Authors:  Yoshinobu Saito; Hayato Hikita; Yasutoshi Nozaki; Yugo Kai; Yuki Makino; Tasuku Nakabori; Satoshi Tanaka; Ryoko Yamada; Minoru Shigekawa; Takahiro Kodama; Ryotaro Sakamori; Tomohide Tatsumi; Tetsuo Takehara
Journal:  Cell Death Differ       Date:  2018-05-31       Impact factor: 15.828

Review 2.  Acetaminophen: Dose-Dependent Drug Hepatotoxicity and Acute Liver Failure in Patients.

Authors:  Hartmut Jaeschke
Journal:  Dig Dis       Date:  2015-07-06       Impact factor: 2.404

3.  A Cytochrome P450-Independent Mechanism of Acetaminophen-Induced Injury in Cultured Mouse Hepatocytes.

Authors:  Kazuhisa Miyakawa; Ryan Albee; Lynda G Letzig; Andreas F Lehner; Michael A Scott; John P Buchweitz; Laura P James; Patricia E Ganey; Robert A Roth
Journal:  J Pharmacol Exp Ther       Date:  2015-06-11       Impact factor: 4.030

Review 4.  The Inflammatory Signal Adaptor RIPK3: Functions Beyond Necroptosis.

Authors:  K Moriwaki; F K-M Chan
Journal:  Int Rev Cell Mol Biol       Date:  2016-09-22       Impact factor: 6.813

Review 5.  Necroptosis: an emerging type of cell death in liver diseases.

Authors:  Waqar Khalid Saeed; Dae Won Jun
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

6.  Mechanisms of acetaminophen-induced cell death in primary human hepatocytes.

Authors:  Yuchao Xie; Mitchell R McGill; Kenneth Dorko; Sean C Kumer; Timothy M Schmitt; Jameson Forster; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2014-06-03       Impact factor: 4.219

7.  The pseudokinase MLKL mediates programmed hepatocellular necrosis independently of RIPK3 during hepatitis.

Authors:  Claudia Günther; Gui-Wei He; Andreas E Kremer; James M Murphy; Emma J Petrie; Kerstin Amann; Peter Vandenabeele; Andreas Linkermann; Christopher Poremba; Ulrike Schleicher; Christin Dewitz; Stefan Krautwald; Markus F Neurath; Christoph Becker; Stefan Wirtz
Journal:  J Clin Invest       Date:  2016-10-17       Impact factor: 14.808

Review 8.  Programmed necrosis in the cross talk of cell death and inflammation.

Authors:  Francis Ka-Ming Chan; Nivea Farias Luz; Kenta Moriwaki
Journal:  Annu Rev Immunol       Date:  2014-12-10       Impact factor: 28.527

9.  Acetaminophen knocks on death's door and receptor interacting protein 1 kinase answers.

Authors:  Maria Eugenia Guicciardi; Gregory J Gores; Hartmut Jaeschke
Journal:  Hepatology       Date:  2015-09-30       Impact factor: 17.425

Review 10.  A Mechanistic Review of Cell Death in Alcohol-Induced Liver Injury.

Authors:  Shaogui Wang; Pal Pacher; Robert C De Lisle; Heqing Huang; Wen-Xing Ding
Journal:  Alcohol Clin Exp Res       Date:  2016-04-30       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.